曲安奈德结构式
|
常用名 | 曲安奈德 | 英文名 | Triamcinolone acetonide |
---|---|---|---|---|
CAS号 | 76-25-5 | 分子量 | 434.498 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 576.9±50.0 °C at 760 mmHg | |
分子式 | C24H31FO6 | 熔点 | 274-278ºC (dec.) | |
MSDS | 中文版 美版 | 闪点 | 302.7±30.1 °C | |
符号 |
GHS08 |
信号词 | Danger |
曲安奈德用途Triamcinolone Acetonide的有效性是prednisone的八倍。 |
中文名 | 曲安奈德 |
---|---|
英文名 | triamcinolone acetonide |
中文别名 | 9-氟-11b,21-二羟基-16a,17-[(1-甲基亚乙基)双(氧)]-孕甾-1,4-二烯-3,20-二酮 | 9-氟-11β,21-二羟基-16α,17-[(1-甲基亚乙基)双(氧)]-孕甾-1,4-二烯-3,20-二酮 | 醋酸曲安缩松 | 去炎松-A | 曲安缩松 | 确炎舒松 |
英文别名 | 更多 |
描述 | Triamcinolone Acetonide的有效性是prednisone的八倍。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 576.9±50.0 °C at 760 mmHg |
熔点 | 274-278ºC (dec.) |
分子式 | C24H31FO6 |
分子量 | 434.498 |
闪点 | 302.7±30.1 °C |
精确质量 | 434.210480 |
PSA | 93.06000 |
LogP | 2.50 |
外观性状 | 白色至灰白色结晶粉末 |
蒸汽压 | 0.0±3.6 mmHg at 25°C |
折射率 | 1.589 |
储存条件 | 本品应密封于阴凉干燥处避光保存。 |
分子结构 | 1、 摩尔折射率:109.41 2、 摩尔体积(m3/mol):324.8 3、 等张比容(90.2K):882.9 4、 表面张力(dyne/cm):54.5 5、 极化率(10 -24cm 3):43.37 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:7 4.可旋转化学键数量:2 5.互变异构体数量:9 6.拓扑分子极性表面积93.1 7.重原子数量:31 8.表面电荷:0 9.复杂度:925 10.同位素原子数量:0 11.确定原子立构中心数量:8 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:白色结晶性粉末。 2. 密度(g/mL,25/4℃):不确定 3. 相对蒸汽密度(g/mL,空气=1):不确定 4. 熔点(ºC):274-278°C 5. 沸点(ºC,常压):不确定 6. 沸点(ºC,5.2kPa):不确定 7. 折射率:不确定 8. 闪点(ºC):不确定 9. 比旋光度(º):不确定 10. 自燃点或引燃温度(ºC):不确定 11. 蒸气压(kPa,25ºC):不确定 12. 饱和蒸气压(kPa,60ºC):不确定 13. 燃烧热(KJ/mol):不确定 14. 临界温度(ºC):不确定 15. 临界压力(KPa):不确定 16. 油水(辛醇/水)分配系数的对数值:不确定 17. 爆炸上限(%,V/V):不确定 18. 爆炸下限(%,V/V):不确定 19. 溶解性:不确定 |
符号 |
GHS08 |
---|---|
信号词 | Danger |
危害声明 | H360 |
警示性声明 | P201-P308 + P313 |
个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) | T:Toxic |
风险声明 (欧洲) | R61 |
安全声明 (欧洲) | S53-S45 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | TU3920000 |
海关编码 | 2937229000 |
海关编码 | 2937229000 |
---|
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.
Br. J. Pharmacol. 172(5) , 1237-49, (2015) Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor that binds to antioxidant response elements located in the promoter region of genes encoding many antioxida... |
|
Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.
J. Steroid Biochem. Mol. Biol. 145 , 94-102, (2015) Triamcinolone acetonide (TA) is prohibited in sport competitions using systemic administrations (e.g., intramuscular, IM), and it is allowed by other routes (e.g., intranasal, IN, or topical, TOP). A ... |
|
A general analytical platform and strategy in search for illegal drugs.
J. Pharm. Biomed. Anal. 100 , 215-29, (2014) An effective screening procedure to identify and quantify active pharmaceutical substances in suspected illegal medicinal products is described. The analytical platform, consisting of accurate mass de... |
Omcilon-A |
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-Fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
(11b,16a)-9-Fluoro-11,21-dihydroxy-16,17-[1-methylethylidenebis(oxy)]pregna-1,4-diene-3,20-dione |
9-Fluoro-11,21-dihydroxy-16,17-[1-methylethylidenebis(oxy)]pregna-1,4-diene-3,20-dione |
9a-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-Acetal with Acetone |
NASACORT |
VOLON A |
Kenacort-A |
Panolog Ointment |
MFCD00056834 |
Tramacin |
2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4b-fluoro-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)- |
9a-Fluoro-16a,17-isopropylidenedioxyprednisolone |
Solodelf |
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-5-hydroxy-6b-(hydroxyacétyl)-4a,6a,8,8-tétraméthyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodécahydro-2H-naphto[2',1':4,5]indéno[1,2-d][1,3]dioxol-2-one |
9a-Fluoro-11b,21-dihydroxy-16a,17a-isopropylidenedioxy-1,4-pregnadiene-3,20-dione |
Adcortyl-A |
respicort |
Triam |
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-Fluor-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-on |
Triamcinolone acetonide acetate |
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4b-fluoro-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)- |
EINECS 200-948-7 |
Triamcinolone 16a,17-Acetonide |
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
Rineton |
Triamcinolone Acetonide |
Azmacort |
volonimat |
9a-Fluoro-16a-hydroxyprednisolone Acetonide |
DELPHICORT |
Kenaquart |
Kenalog |
Triamcinolone (acetonide) |